Şahika Şahinkaya

Şahika Şahinkaya

Auto-generated profile, based on publicly available information

Şahika Şahinkaya

Department of Pediatric Infectious Diseases, Dr. Behçet Uz Children Disease and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2022 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
İDİlker Devrim
İlker Devrim
EBElif Böncüoğlu
Elif Böncüoğlu
EKElif Kıymet
Elif Kıymet
ŞŞŞahika Şahinkaya
Şahika Şahinkaya
MÇMiray Yılmaz Çelebi
Miray Yılmaz Çelebi
NBNuri Bayram
Nuri Bayram
Background: For children with the multisystem inflammatory syndrome(MIS-C), intravenous immunoglobulins (IVIG) with or without methylprednisolone are the most effective treatment. In this study, IVIG combined with methylprednisolone was compared to IVIG used alone in children with MIS-C.Methods: This retrospective cohort study was carried out between April 1, 2020, and November 1, 2021. This study covered all children with MIS-C. According to whether they received IVIG alone or IVIG with methylprednisolone as an initial treatment for MIS-C, the patients were split into two groups. The IVIG dosage for the patients in group I was 2 gr/kg, whereas the IVIG dosage for the patients in group II was 2 gr/kg + 2 mg/kg/day of methylprednisolone. These two groups were contrasted in terms of the frequency of fever, length of hospital stay, and admission to the pediatric intensive care unit.Results: The study comprised 91 patients who were diagnosed with MIS-C and were under the age of 18. 42 (46.2%) of these patients were in the IVIG alone group (group I), and 49 (53.8%) were in the IVIG + methylprednisolone group (group II). Patients in group II had a severe MIS-C ratio of 36.7%, which was substantially greater than the rate of severe MIS-C patients in group I (9.5%) (p 0.01). When compared to group I (9.5%), the rate of hypotension was considerably higher in group II (30.6%) (p = 0.014). Additionally, patients in group II had considerably higher mean serum levels of C-reactive protein. The incidence of fever recurrence was 26.5% in group II and 33.3% in group I, however the difference was not statistically significant (p > 0.05).Conclusions: The choice of treatment for patients with MIS-C should be based on an individual evaluation. In MIS-C children with hypotension and/or with an indication for a pediatric intensive care unit, a combination of IVIG and methylprednisolone may be administered. For the treatment modalities of children with MIS-C, however, randomized double-blind studies are necessary.

23 January 2022 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
MÇMiray Yılmaz Çelebi
Miray Yılmaz Çelebi
EKElif Kıymet
Elif Kıymet
EBElif Böncüoğlu
Elif Böncüoğlu
ŞŞŞahika Şahinkaya
Şahika Şahinkaya
ECEla Cem
Ela Cem
İDİlker Devrim
İlker Devrim
Severe acute respiratory syndrome coronavirus 2 is reappearing with an increasing number of variants every day; this study aimed to determine the effect of B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta) variants on hospitalization rates. This single‐center study was conducted at the University of Health Sciences Dr. Behçet Uz Children's Hospital from March 11 to August 27, 2021. Variant analyses of symptomatic patients admitted to the hospital who were found to be positive for COVID 19 PCR was performed. Out of 680 cases, 329 (48.4%) were B.1.1.7 variant, 17 (2.5%) were B.1.351/P.1 variant, and 165 (24.2%) were B.1.617.2 variant. One hundred and sixty‐nine (24.9%) case variant analysis results were negative. The hospitalization rate of patients with the B.1.617.2 variant was 19.4%, the B.1.351/P.1 variant was 18%, the B.1.1.7 variant was 9.4%, and the negative variant was 10.1%. The B.1.617.2 (Delta) variant, which has become widespread all over the world recently, increases the rate of hospitalization in children.

9 October 2022 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
GOGizem Guner Ozenen
Gizem Guner Ozenen
AKAybuke Akaslan Kara
Aybuke Akaslan Kara
EKElif Kiymet
Elif Kiymet
EBElif Böncüoğlu
Elif Böncüoğlu
SSSahika Sahinkaya
Sahika Sahinkaya
İDİlker Devrim
İlker Devrim

8 July 2022 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
ECEla Cem
Ela Cem
EBElif Böncüoğlu
Elif Böncüoğlu
EKElif Kıymet
Elif Kıymet
ŞŞŞahika Şahinkaya
Şahika Şahinkaya
MÇMiray Yılmaz Çelebi
Miray Yılmaz Çelebi
İDİlker Devrim
İlker Devrim

13 May 2021 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
EBElif Böncüoğlu
Elif Böncüoğlu
MCMehmet Coşkun
Mehmet Coşkun
EKElif Kıymet
Elif Kıymet
TATülay Öztürk Atasoy
Tülay Öztürk Atasoy
ŞŞŞahika Şahinkaya
Şahika Şahinkaya
İDİlker Devrim
İlker Devrim

25 January 2022 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
İDİlker Devrim
İlker Devrim
EBElif Böncüoğlu
Elif Böncüoğlu
EKElif Kıymet
Elif Kıymet
ŞŞŞahika Şahinkaya
Şahika Şahinkaya
MÇMiray Yılmaz Çelebi
Miray Yılmaz Çelebi
NBNuri Bayram
Nuri Bayram
There are two major pandemics in the new millennium, including the pandemic of swine influenza and the COVID‐19 pandemic. These two pandemics affected children as well as the adult population. In this case‐control study, we compared children with COVID‐19 infection and those with H1N1pdm09 virus infection. We also compared the demographic factors, underlying disease, and the requirement for intensive care admission between the hospitalized children with COVID‐19 infection and children with H1N1pdm09 virus infection who were hospitalized during the 2009 H1N1 pandemic. In this study, we evaluated 103 patients with H1N1pdm09 virus infection and 392 patients with COVID‐19 infection. The age was significantly higher in the COVID‐19 patients' group compared to the pandemic influenza group (p < 0.001). The ratio of the children ≥12 years was 10.7% (n = 11) in the H1N1pdm09 virus infection and 36.2% (n = 142) in the COVID‐19 group. The rate of underlying disease was significantly higher in the patients with H1N1pdm09 virus infections (p = 0.02). The prevalence of underlying disease in patients requiring PICU hospitalization was 69.2% (n = 9/13) compared to 25.7% (n = 124/482) in patients who did not require PICU hospitalization. The rate of underlying disease was significantly higher in the PICU group regardless of COVID‐19 or H1N1pdm09 virus (p = 0.002). Our results suggest that older children were more hospitalized for COVID‐19 infections compared to pandemic influenza. In addition, regardless of the type of pandemic infection, the underlying disease is an important factor for pediatric intensive care unit admission. This finding is important for developing strategies for the protection of children with the underlying disease in the upcoming pandemics.